Basics |
Company: |
Akoya BioSciences, Inc. |
IPO Date: |
April 12, 2021 |
Sector: |
Healthcare |
Industry: |
Medical Instruments and Supplies |
Market Cap: |
$101.62M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.29 | 3.34%
|
Avg Daily Range (30 D): |
$0.10 | 3.71%
|
Avg Daily Range (90 D): |
$0.09 | 3.69%
|
Institutional Daily Volume |
Avg Daily Volume: |
.16M |
Avg Daily Volume (30 D): |
.89M |
Avg Daily Volume (90 D): |
.42M |
Trade Size |
Avg Trade Size (Sh.): |
98 |
Avg Trade Size (Sh.) (30 D): |
136 |
Avg Trade Size (Sh.) (90 D): |
135 |
Institutional Trades |
Total Inst.Trades: |
105 |
Avg Inst. Trade: |
$1.98M |
Avg Inst. Trade (30 D): |
$.97M |
Avg Inst. Trade (90 D): |
$.97M |
Avg Inst. Trade Volume: |
.15M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.83M |
Avg Closing Trade (30 D): |
$.97M |
Avg Closing Trade (90 D): |
$.97M |
Avg Closing Volume: |
156.81K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-1.16
|
$-.21
|
$-.27
|
Diluted EPS
|
$-1.16
|
$-.21
|
$-.27
|
Revenue
|
$ 86.82M
|
$ 18.81M
|
$ 23.16M
|
Gross Profit
|
$ 50.11M
|
$ 11.72M
|
$ 13.39M
|
Net Income / Loss
|
$ -57.97M
|
$ -10.53M
|
$ -13.15M
|
Operating Income / Loss
|
$ -50.46M
|
$ -8.35M
|
$ -11.08M
|
Cost of Revenue
|
$ 36.71M
|
$ 7.09M
|
$ 9.78M
|
Net Cash Flow
|
$ -65.69M
|
$ 3.61M
|
$ -4.11M
|
PE Ratio
|
|
|
|
|